Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple marker approach to risk stratification in patients with stable coronary artery disease.
Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wollert KC, Benjamin EJ, Lackner KJ, Münzel TF, Tiret L, Vasan RS, Blankenberg S. Schnabel RB, et al. Among authors: cambien f. Eur Heart J. 2010 Dec;31(24):3024-31. doi: 10.1093/eurheartj/ehq322. Epub 2010 Sep 18. Eur Heart J. 2010. PMID: 20852293
Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Münzel T, Cambien F, Tiret L, Blankenberg S; AtheroGene Investigators. Schnabel R, et al. Among authors: cambien f. Eur Heart J. 2005 Feb;26(3):241-9. doi: 10.1093/eurheartj/ehi036. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15618051
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T. Schnabel R, et al. Among authors: cambien f. Circ Res. 2005 Sep 2;97(5):e53-9. doi: 10.1161/01.RES.0000181286.44222.61. Epub 2005 Aug 11. Circ Res. 2005. PMID: 16100045
Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk.
Blankenberg S, Godefroy T, Poirier O, Rupprecht HJ, Barbaux S, Bickel C, Nicaud V, Schnabel R, Kee F, Morrison C, Evans A, Lackner KJ, Cambien F, Münzel T, Tiret L; AtheroGene Investigators. Blankenberg S, et al. Among authors: cambien f. Circ Res. 2006 Jul 7;99(1):102-8. doi: 10.1161/01.RES.0000232324.87983.4b. Epub 2006 Jun 15. Circ Res. 2006. PMID: 16778130
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Münzel T, Yusuf S; HOPE Study Investigators. Blankenberg S, et al. Among authors: cambien f. Circulation. 2006 Jul 18;114(3):201-8. doi: 10.1161/CIRCULATIONAHA.105.590927. Epub 2006 Jul 10. Circulation. 2006. PMID: 16831981 Clinical Trial.
356 results